Optimized small guide RNAs and methods of use

US10822606B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10822606-B2
Application numberUS-201415025217-A
CountryUS
Kind codeB2
Filing dateSep 29, 2014
Priority dateSep 27, 2013
Publication dateNov 3, 2020
Grant dateNov 3, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods, compositions, and kits are provided herein for CRISPER/Cas-mediated nucleic acid detection or modification.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of genome imaging a target nucleic acid sequence in a living cell nucleus, the method comprising: (i) introducing into the living cell: (a) one or more small guide RNAs (sgRNAs) comprising sequences of SEQ ID NO:4, SEQ ID NO:8, and/or SEQ ID NO:17, wherein each of the sgRNAs is specific for the target nucleic acid sequence in the living cell nucleus; and (b) a first labeled nuclease-deficient Cas9 (dCas9), thereby forming a first labeled complex comprising at least one of the sgRNAs and the first labeled dCas9; and (ii) incubating the living cell to allow the first labeled complex to localize to the target nucleic acid sequence in the living cell nucleus; and (iii) imaging the presence or quantity of the first labeled complex in the nucleus of the living cell, thereby imaging the target nucleic acid. 2. The method of claim 1 , wherein the one or more sgRNAs comprise at least 2 different sgRNAs, each specific for a different portion of the target nucleic acid sequence. 3. The method of claim 1 , wherein the one or more sgRNAs are specific for a repeated target sequence. 4. The method of claim 1 , wherein the introducing further comprises forming a second labeled complex comprising the one or more sgRNAs and a second labeled dCas9; and contacting the living cell with the second labeled complex. 5. The method of claim 4 , wherein the first and second labeled complexes are specific for a different target nucleic acid sequence in the living cell nucleus or specific for a different region of a chromosome in the living cell nucleus. 6. The method of claim 4 , wherein the first and second labeled complexes are labeled with a different label, and the method comprises imaging the presence or quantity of the first and second labeled complexes in the nucleus of the living cell, thereby imaging the target nucleic acid. 7. A method of genome imaging a target nucleic acid sequence in a living cell nucleus, the method comprising: (i) introducing into the living cell: (a) one or more small guide RNAs (sgRNAs) comprising a sequence of SEQ ID NO:4 and/or SEQ ID NO:8, wherein each of the sgRNAs is specific for the target nucleic acid sequence in the living cell nucleus; and (b) a first labeled nuclease-deficient Cas9 (dCas9), thereby forming a first labeled complex comprising at least one of the sgRNAs and the first labeled dCas9; and (ii) incubating the living cell to allow the first labeled complex to localize to the target nucleic acid sequence in the living cell nucleus; and (iii) imaging the presence or quantity of the first labeled complex in the nucleus of the living cell, thereby imaging the target nucleic acid. 8. The method of claim 1 , wherein the one or more sgRNAs comprise SEQ ID NO:4. 9. The method of claim 1 , wherein the first labeled dCas9 comprises a Cas9 protein containing a mutation at one or more of the following residues: D10, G12, G17, E762, H840, N854, N863, H982, H983, A984, D986, or A987.

Assignees

Inventors

Classifications

  • C12N9/22Primary

    Ribonucleases {[RNase]; Deoxyribonucleases [DNase]} · CPC title

  • Type of nucleic acid · CPC title

  • involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

  • General methods applicable to biologically active non-coding nucleic acids · CPC title

  • Hydrolases acting on ester bonds (3.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10822606B2 cover?
Methods, compositions, and kits are provided herein for CRISPER/Cas-mediated nucleic acid detection or modification.
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification C12N9/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).